Abstract:Summary Background ALKBH5 belongs to the ALKB family consists of a Fe (II) and a-ketoglutarate-dependent dioxygenase. ALKBH5 directly catalyzes the oxidative demethylation of m6A-methylated adenosine. ALKBH5 involves in tumorigenesis and tumor progression, and is often dysregulated in a wide range of cancers, including colorectal cancer. Emerging evidence indicates that the expression of ALKBH5 is associated with the abundance of infiltrating immune cells in the microenvironment. However, how ALKBH5 affects immune cell infiltration in the microenvironment in colorectal cancer (CRC) has not been reported. The aim of this study was to identify how the expression of ALKBH5 affects the biological behaviors of CRC cell lines and regulates the effects on infiltrating CD8 + T cells in CRC microenvironment with its specific mechanism. Methods Firstly, the transcriptional expression profiles of CRC were downloaded from TCGA database and integrated via R software (4.1.2). Between CRC and normal colorectal tissues, ALKBH 5 mRNA expressions were compared (Wilcoxon rank-sum). We further identified the expression levels of ALKBH5 in CRC tissues and cell lines through quantitative PCR, western blot, and immunohistochemistry. Then, how ALKBH5 affects the biological behaviors of CRC cells were confirmed by gain- and loss-of-function analysis. Furthermore, the relationship between ALKBH5 level and 22 tumor-infiltrating immune cells was examined through CIBERSORT in R software. Furthermore, we explored the correlation between ALKBH5 expression and tumor-infiltrated CD8 + , CD4 + and regulatory T cells by utilizing the TIMER database. Finally, the association between chemokines and CD8 + T cells infiltration in CRC was analyzed using GEPIA online database. qRT-PCR, WB and IHC were used to further determine the effect of ALKBH5 on NF-κB-CCL5 signaling axis and CD8 + T cells infiltration. Results Clinically, ALKBH5 expression was downregulated in CRC and low levels of ALKBH5 expression were correlated with poor overall survival (OS). Functionally, overexpression of ALKBH 5 reduced the proliferation, migration and invasion of CRC cells, and vice versa. Overexpression of ALKBH 5 suppresses NF-κB pathway, thus reduces CCL5 expression and promotes CD8 + T cells infiltration in CRC microenvironment. Conclusions ALKBH5 is poorly expressed in CRC, and overexpression of ALKBH 5 attenuates CRC malignant progression by inhibiting CRC cell proliferation, migration, invasion and promoting CD8 + T cells infiltration in the tumor microenvironment through NF-κB-CCL5 axis.

Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs

ALKBH1-Mediated tRNA Demethylation Regulates Translation

RNA Demethylase ALKBH5 in Cancer: from Mechanisms to Therapeutic Potential.

N1-methyladenosine methylation in mRNAs drives bladder cancer progression

ALKBH1 promotes lung cancer by regulating m6A RNA demethylation

The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance

RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.

The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1

Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies

ALKBH1‐mediated M1a Demethylation of METTL3 Mrna Promotes the Metastasis of Colorectal Cancer by Downregulating SMAD7 Expression

Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer

N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression

RNA Demethylase ALKBH5 Promotes Tumorigenesis of T (8;21) Acute Myeloid Leukemia Via ITPA M6a Modification

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

The Molecular Basis of Human ALKBH3 Mediated RNA N1‐methyladenosine (m1a) Demethylation

RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8 + T cell infiltration in colorectal cancer